JP2023541771A5 - - Google Patents
Info
- Publication number
- JP2023541771A5 JP2023541771A5 JP2023504005A JP2023504005A JP2023541771A5 JP 2023541771 A5 JP2023541771 A5 JP 2023541771A5 JP 2023504005 A JP2023504005 A JP 2023504005A JP 2023504005 A JP2023504005 A JP 2023504005A JP 2023541771 A5 JP2023541771 A5 JP 2023541771A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063054180P | 2020-07-20 | 2020-07-20 | |
| US63/054,180 | 2020-07-20 | ||
| US202163172626P | 2021-04-08 | 2021-04-08 | |
| US63/172,626 | 2021-04-08 | ||
| PCT/CA2021/051006 WO2022016270A1 (en) | 2020-07-20 | 2021-07-20 | Fusion proteins comprising a ligand-receptor pair and a biologically functional protein |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023541771A JP2023541771A (ja) | 2023-10-04 |
| JPWO2022016270A5 JPWO2022016270A5 (https=) | 2024-07-29 |
| JP2023541771A5 true JP2023541771A5 (https=) | 2024-07-29 |
| JP7846668B2 JP7846668B2 (ja) | 2026-04-15 |
Family
ID=79729591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504005A Active JP7846668B2 (ja) | 2020-07-20 | 2021-07-20 | リガンド－受容体対及び生物学的に機能的なタンパク質を含む融合タンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230331809A1 (https=) |
| EP (1) | EP4182357A4 (https=) |
| JP (1) | JP7846668B2 (https=) |
| KR (1) | KR20230042315A (https=) |
| CN (1) | CN116171167B (https=) |
| AU (1) | AU2021312554A1 (https=) |
| CA (1) | CA3145387A1 (https=) |
| MX (1) | MX2023000839A (https=) |
| WO (1) | WO2022016270A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7773991B2 (ja) * | 2020-03-23 | 2025-11-20 | ザイムワークス ビーシー インコーポレイテッド | マスクされたｉｌ１２融合タンパク質及びその使用方法 |
| WO2023141713A1 (en) * | 2022-01-26 | 2023-08-03 | Zymeworks Bc Inc. | Immunomodulatory trispecific t cell engager fusion proteins |
| US20240254223A1 (en) * | 2022-09-02 | 2024-08-01 | Novimmune Sa | Reciprocally masked antibody-cytokine fusion proteins and methods of use thereof |
| AU2023366004A1 (en) * | 2022-10-19 | 2025-06-05 | Zymeworks Bc Inc. | Trivalent and trispecific antibody constructs and methods of use thereof |
| CN116574748B (zh) * | 2023-07-10 | 2023-09-12 | 昆明医科大学 | 一种用于靶向KRAS高频突变肿瘤的嵌合型nTCR-T构建方法 |
| AU2024330202A1 (en) * | 2023-08-25 | 2026-02-12 | Ibio, Inc. | High-efficiency, conditionally-activated antibody discovery and masked antibodies |
| WO2025117851A1 (en) * | 2023-11-30 | 2025-06-05 | The General Hospital Corporation | Meso-fap with adam17 inhibitor or itk inhibitor |
| WO2025133042A2 (en) * | 2023-12-22 | 2025-06-26 | F. Hoffmann-La Roche Ag | Activatable fusion proteins and methods of use |
| WO2025170315A1 (ko) * | 2024-02-05 | 2025-08-14 | 주식회사 트리오어 | 이중 기능 도메인을 포함하는 융합단백질 및 이의 용도 |
| KR20250161096A (ko) * | 2024-05-07 | 2025-11-17 | 바이티디 주식회사 | Vista 및 msln에 특이적으로 결합하는 이중특이적 항체 및 이의 용도 |
| WO2025247847A1 (en) | 2024-05-30 | 2025-12-04 | Zytox Therapeutics Ab | A matriptase-cleavable substrate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201608307WA (en) | 2012-04-20 | 2016-11-29 | Emergent Product Dev Seattle | Cd3 binding polypeptides |
| WO2015095404A2 (en) | 2013-12-17 | 2015-06-25 | Genentech, Inc. | Methods of treating cancers using pd-1 axis binding antagonists and taxanes |
| HRP20230528T1 (hr) | 2016-03-22 | 2023-08-04 | F. Hoffmann - La Roche Ag | Bispecifične molekule t stanica aktivirane proteazom |
| EP3625253A4 (en) * | 2017-05-16 | 2021-03-24 | Scalmibio, Inc. | ACTIVABLE ANTIBODIES AND THEIR METHODS OF USE |
| WO2019080883A1 (en) | 2017-10-26 | 2019-05-02 | Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd. | NOVEL RECOMBINANT FUSION PROTEINS, PREPARATION THEREOF AND USE THEREOF |
| CA3120800A1 (en) * | 2018-12-17 | 2020-06-25 | Revitope Limited | Twin immune cell engager |
-
2021
- 2021-07-20 CN CN202180051531.1A patent/CN116171167B/zh active Active
- 2021-07-20 CA CA3145387A patent/CA3145387A1/en active Pending
- 2021-07-20 JP JP2023504005A patent/JP7846668B2/ja active Active
- 2021-07-20 MX MX2023000839A patent/MX2023000839A/es unknown
- 2021-07-20 AU AU2021312554A patent/AU2021312554A1/en active Pending
- 2021-07-20 WO PCT/CA2021/051006 patent/WO2022016270A1/en not_active Ceased
- 2021-07-20 KR KR1020237005797A patent/KR20230042315A/ko active Pending
- 2021-07-20 US US18/017,319 patent/US20230331809A1/en active Pending
- 2021-07-20 EP EP21845766.1A patent/EP4182357A4/en active Pending